Institutional investors and hedge funds have recently made changes to their positions in the stock market. Gofen & Glossberg LLC IL increased its stake in IM Cannabis by 100.0% during the first quarter. Gofen & Glossberg LLC IL now owns 20,000 shares of the company’s shares valued at $ 43,000 after buying an additional 10,000 shares during the last quarter. Millennium Management LLC bought a new stake in IM Cannabis during the second quarter valued at about $ 182,000. Jane Street Group LLC increased its stake in IM Cannabis by 130.5% during the third quarter. Jane Street Group LLC now owns 36,461 shares of the company’s shares valued at $ 129,000 after buying an additional 20,641 shares during the last quarter. Baader Bank INC increased its stake in IM Cannabis by 27.7% during the first quarter. Baader Bank INC now owns 235,000 shares of the company’s shares valued at $ 503,000 after buying an additional 50,904 shares during the last quarter. Finally, AdvisorShares Investments LLC increased its stake in IM Cannabis by 66.4% during the fourth quarter. AdvisorShares Investments LLC now owns 692,947 shares of the company’s shares valued at $ 2,314,000 after buying an additional 276,554 shares during the last quarter. Institutional investors own 18.43% of the company’s shares.
Shares of IMCC shares fell $ 0.05 during trading hours on Friday, to $ 0.87. 336,636 shares of shares have been exchanged, compared to its average volume of 91,206. IM Cannabis has a 12 month low of $ 0.75 and a 12 month high of $ 6.35. The company has a current ratio of 1.47, a fast ratio of 0.88 and a debt-to-equity ratio of 0.09. The company’s 50-day moving average price is $ 1.31 and the 200-day moving average price is $ 2.18. The company has a market capitalization of $ 60.63 million and a price-to-earnings ratio of -1.43.
IM Cannabis (NASDAQ: IMCC – Get Rating) last announced its quarterly earnings data on Thursday, March 31st. The company reported earnings per share of ($ 0.15) during the quarter, missing analyst consensus estimates of ($ 0.03) for ($ 0.12). IM Cannabis had a negative net margin of 44.71% and a negative return on equity of 16.28%. The company had revenue of $ 15.96 million during the quarter. On average, sales analysts expect IM Cannabis to record -0.15 EPS for the current year.
About IM Cannabis (Get a score)
IM Cannabis Corp. is engaged in the breeding, cultivation and supply of medicinal cannabis products in Israel, Germany and Canada. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and offers dried flowers, pre-rolls and pressed hashish under the WAGNERS and Highland Grow brands.
Get IM Cannabis Daily news and ratings – Enter your email address below to receive a concise daily summary of the latest news and ratings from IM Cannabis analysts and companies related to the FREE Daily MarketBeat.com email newsletter.